A phase I study of TGF-β inhibitor, vactosertib in combination with imatinib in patients with advanced desmoid tumor (aggressive fibromatosis).

Hyo Song Kim,Jin-Hee Ahn,Jeong Eun Kim,Jung Yong Hong,Jeeyun Lee,Sung Hyun Kim,Jin Lee,Sunjin Hwang,Min-Kyung Jeon,Seong-Jin Kim

A phase I study of TGF-β inhibitor, vactosertib in combination with imatinib in patients with advanced desmoid tumor (aggressive fibromatosis).

2020

Hyo Song Kim
Jin-Hee Ahn
Jeong Eun Kim
Jung Yong Hong
Jeeyun Lee
Sung Hyun Kim
Jin Lee
Sunjin Hwang
Min-Kyung Jeon
Seong-Jin Kim

11557Background: Desmoid tumor (aggressive fibromatosis) is fibroproliferative neoplasm arising from deep connective tissues. TCGA pan-cancer analysis revealed high expression TGF-β responsive sign...

Keywords:

Imatinib
Transforming growth factor
phase i study
in patient
Pathology
Cancer research
Aggressive fibromatosis
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations